Member Info for Rocket79

The only thing holding down shareprice from being 20p is Rex selling. Once he has cleared the share price will reflect truevalue imo.

Sorry eldorado I don't think your analysis is correct. This could easily be over 20p in the next few months or 10p. Risk reward is now worth buying at this level imo. This could easily double by Christmas. Good luck

Whitman Howard Today R1 has announced a positive trading update and the continued restructuring of the business with CFO Ed Reginelli resigning and being replaced by Mark Zorko. This is consistent with continued execution of R1 financial plan focused on accelerating growth and profitability. We retain our Buy and 770p price target.

This is now at bottom and will rise from these levels imo. There is strong support below this level.

N+1 Singer Note Alongside the CFO change announcement, RTHM included a compact update on trading. While H1 revenues are off plan (weak Performance market and integration disruption), lasting effects look likely to be modest and the biggest implication of H1 EBITDA guidance is that costs have been reduced much faster than expected, providing comfort for the full year. EBITDA looks set to continue to soar and investors are likely to focus on H1 19 EBITDA progress; c$20m compares very favourably with $3.1m in H1 18 and $14.0m for all of FY18. Our new FY19 forecast is for $48m. The stock trades on just 3.6x FY19 EV/EBITDA. We adjust our TP to 533p (was 730p) implying investors can more than double their money. BUY.

Patience here will be rewarded. This is oversold imo and with price targets from N1 Singer of 533p and Whitman Howard 720p i am confident we will rise from these low levels. Good luck all

I think he must be lonely, Or needs help? maybe both. He posts here as he has no friends and has nothing better to do in his life. I fell sorry for stt

Whitman Howard Today R1 has announced a positive trading update and the continued restructuring of the business with CFO Ed Reginelli resigning and being replaced by Mark Zorko. This is consistent with continued execution of R1 financial plan focused on accelerating growth and profitability. We retain our Buy and 770p price target.

That's what I am thinking. Any leak of a merger with S4 and the share price would rocket. R1 is cheap at current price.

N+1 Singer Note Alongside the CFO change announcement, RTHM included a compact update on trading. While H1 revenues are off plan (weak Performance market and integration disruption), lasting effects look likely to be modest and the biggest implication of H1 EBITDA guidance is that costs have been reduced much faster than expected, providing comfort for the full year. EBITDA looks set to continue to soar and investors are likely to focus on H1’19 EBITDA progress; c$20m compares very favourably with $3.1m in H1’18 and $14.0m for all of FY18. Our new FY19 forecast is for $48m. The stock trades on just 3.6x FY19 EV/EBITDA. We adjust our TP to 533p (was 730p) implying investors can more than double their money. BUY.

26 Sep 2018 Trimming numbers, but profits are leaping Rhythmone | RTHM | 208 -14.6 (-3.3%) | Mkt Cap: 163.3m N+1 Singer Johnathan Barrett 3 pages Web image Alongside the CFO change announcement, RTHM included a compact update on trading. While H1 revenues are off plan (weak Performance market and integration disruption), lasting effects look likely to be modest and the biggest implication of H1 EBITDA guidance is that costs have been reduced much faster than expected, providing comfort for the full year. EBITDA looks set to continue to soar and investors are likely to focus on H1’19 EBITDA progress; c$20m compares very favourably with $3.1m in H1’18 and $14.0m for all of FY18. Our new FY19 forecast is for $48m. The stock trades on just 3.6x FY19 EV/EBITDA. We adjust our TP to 533p (was 730p) implying investors can more than double their money. BUY.

26 Sep 2018 Trimming numbers, but profits are leaping Rhythmone | RTHM | 208 -14.6 (-3.3%) | Mkt Cap: 163.3m N+1 Singer Johnathan Barrett 3 pages Alongside the CFO change announcement, RTHM included a compact update on trading. While H1 revenues are off plan (weak Performance market and integration disruption), lasting effects look likely to be modest and the biggest implication of H1 EBITDA guidance is that costs have been reduced much faster than expected, providing comfort for the full year. EBITDA looks set to continue to soar and investors are likely to focus on H1’19 EBITDA progress; c$20m compares very favourably with $3.1m in H1’18 and $14.0m for all of FY18. Our new FY19 forecast is for $48m. The stock trades on just 3.6x FY19 EV/EBITDA. We adjust our TP to 533p (was 730p) implying investors can more than double their money. BUY.

Whitman Howard Today R1 has announced a positive trading update and the continued restructuring of the business with CFO Ed Reginelli resigning and being replaced by Mark Zorko. This is consistent with continued execution of R1 financial plan focused on accelerating growth and profitability. We retain our Buy and 770p price target.

Today R1 has announced a positive trading update and the continued restructuring of the business with CFO Ed Reginelli resigning and being replaced by Mark Zorko. This is consistent with continued execution of R1 financial plan focused on accelerating growth and profitability. We retain our Buy and 770p price target.

https://www.campaignlive.co.uk/article/agency-will-martin-sorrell-scoop-next/1487548 Tosca are our biggest share holder and have also bought over 13% in S4. I think R1 will be on the list of takeover/merger targets also. Dyor

Tosca is also a share holder in S4 Capital. Maybe they could be working on a merger/takeover of R1? No smoke without fire imo

Ok S4 capital current has a market cap of £220 mil Vs R1 £175 mil. S4 had £100 mil revenue in 2018. R1 forcast to have over $400 this year and mvap still below S4. This shows how undervalued R1 is. Strong Buy imo

After 240 next resistance is 250p then 300p. Expecting a rise from this depressed level. Good luck

The stock trades on just 3.6x FY19 EV/EBITDA. Now that's ridiculously cheap

£5.33 price target is not negative. Shows how undervalued R1 are. If they hit N+1 Singer Note EBITDA which I am confident will happen then there will be an upgrade and £533p will be a distant memory.